The new workflow enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development, and precision medicine
The review is authored by a multidisciplinary team of experts from AMP and APHL, including the SARS-CoV-2 Whole Genome Sequencing Working Group
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.